Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1–2 N1 disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Radiology Nuclear Medicine and imaging
Link
http://link.springer.com/article/10.1007/s00066-018-1343-x/fulltext.html
Reference20 articles.
1. Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E et al (2015) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Suppl 5):v8–v30
2. Salerno KE (2017) NCCN guidelines update: evolving radiation therapy recommendations for breast cancer. J Natl Compr Canc Netw 15(5s):682–684
3. Gradishar W, Salerno KE (2016) NCCN guidelines update: breast cancer. J Natl Compr Canc Netw 14(5 Suppl):641–644
4. Wenz F, Sperk E, Budach W, Dunst J, Feyer P, Fietkau R et al (2014) DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer. Strahlenther Onkol 190(8):705–714
5. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337(14):956–962
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Who can benefit from postmastectomy radiotherapy among HR+/HER2- T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach;Frontiers in Endocrinology;2024-02-02
2. De-escalated radiotherapy for HER2-overexpressing breast cancer patients with 1-3 positive lymph nodes undergoing anti-HER2 targeted therapy;Frontiers in Oncology;2023-11-01
3. The Clinical survival benefit of postmastectomy radiotherapy patients screened from T1-2N1M0 breast cancer according to tumor size and the number of lymph nodes;2023-10-24
4. Postmastectomy radiotherapy in patients with T1-2N1 breast cancer: a single center experience and a meta-analysis;Journal of Cancer Research and Clinical Oncology;2023-05-31
5. Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy;Frontiers in Oncology;2023-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3